Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 222,814,974 papers from all fields of science
Search
Sign In
Create Free Account
ingenol mebutate 0.0005 MG/MG Topical Gel
Known as:
INGENOL MEBUTATE 0.05% GEL,TOP [VA Product]
, INGENOL MEBUTATE 0.05% TOP GEL
, ingenol mebutate 0.05 % Topical Gel
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Topical Gel
ingenol mebutate
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
miR-34 modulates apoptotic gene expression in Ingenol mebutate treated keloid fibroblasts
B. De Felice
,
F. Manfellotto
,
C. Garbi
,
M. Santoriello
,
M. Nacca
Molecular Medicine Reports
2018
Corpus ID: 4640541
Keloids are benign skin tumors that develop in individuals who have a positive family history of keloid disorders. Keloids are…
Expand
2018
2018
Pharmacokinetics of ingenol mebutate gel under maximum use conditions in large treatment areas
A. Bucko
,
M. Jarratt
,
D. Stough
,
Laerke K Kyhl
,
J. Villumsen
,
A. Hall
Journal of dermatological treatment (Print)
2018
Corpus ID: 4701432
Abstract Purpose: Actinic keratoses (AKs) exist on a continuum with squamous cell carcinoma and can occur as sub-clinical and…
Expand
2018
2018
A multicentre, open, investigator‐initiated phase IV clinical trial to evaluate the efficacy and safety of ingenol mebutate gel, 0·015% on the face and scalp, and 0·05% on the trunk and extremities…
Y. C. Kim
,
J. Y. Yang
,
+7 authors
I.H. Kim
British Journal of Dermatology
2018
Corpus ID: 3619922
Ingenol mebutate gel is a novel, field‐directed topical treatment for actinic keratosis (AK). Most pivotal studies have targeted…
Expand
2018
2018
Fast Ablation of Anogenital Warts of the Urinary Meatus by Low-dose Ingenol Mebutate Gel.
S. Braun
,
M. Barsch
,
P. Gerber
Sexually Transmitted Diseases
2018
Corpus ID: 44082350
Therapeutic options of anogenital warts (AGW) at the urethral meatus are limited and often require effortful and time-consuming…
Expand
2016
2016
Ingenol Mebutate for Recalcitrant Chronic Actinic Cheilitis
E. Tzika
,
I. Masouyé
,
M. Mühlstädt
,
E. Laffitte
Dermatology
2016
Corpus ID: 46669568
We present the case of a healthy 76-year-old man with a whitish, hyperkeratotic lesion of the lower lip diagnosed as actinic…
Expand
2016
2016
Biological Effects of Ingenol Mebutate Gel in Moderate to Severe Actinic Fields Assessed by Reflectance Confocal Microscopy: A Phase I Study.
M. Ulrich
,
S. Lange‐Asschenfeldt
,
+5 authors
E. Stockfleth
Journal of Drugs in Dermatology
2016
Corpus ID: 36518973
Ingenol mebutate represents a topical treatment for fields with actinic keratosis (AK). The biological effects of ingenol…
Expand
2016
2016
Ingenol Mebutate for Lentigo Maligna: A Case Report
K. Gadaldi
,
L. Feldmeyer
,
N. Yawalkar
,
R. Hunger
Dermatology
2016
Corpus ID: 5058055
Background: Lentigo maligna (LM) is a melanoma in situ on sun-damaged skin, with a strong predilection to the head and neck area…
Expand
2015
2015
Cosmetic Effects of Ingenol Mebutate Gel in the Treatment of Field-Cancerized Photodamaged Skin.
S. Braun
,
P. Gerber
Dermatologic Surgery
2015
Corpus ID: 205583256
Figure 1. (A) Scalp of an 82-year-old patient with actinic field cancerization and mottled pigmentation. In the marked area, 1…
Expand
2013
2013
Ingenol Mebutate for the Treatment of Actinic Keratosis
Andrea Hui
,
O. Markowitz
Current Dermatology Reports
2013
Corpus ID: 72654099
Actinic keratoses (AKs) are common premalignant lesions that have the potential to evolve into squamous cell carcinoma (SCC) if…
Expand
2012
2012
Ingenol mebutate: induced cell death patterns in normal and cancer epithelial cells.
M. Stahlhut
,
M. Bertelsen
,
+6 authors
J. Zibert
Journal of Drugs in Dermatology
2012
Corpus ID: 26057721
We investigated the proposed necrotic mechanism of ingenol mebutate, a natural compound with anti-cancer properties in human…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE